Multimedia News Request a Demo Contact Us Join Our Email List Home

Integrated inpatient software for IV insulin
management with the mission of improving glycemic control

Reduces the frequency, risk, and cost of hyperglycemia, hypoglycemia and glycemic varibility


Proven Tool  |  By the Numbers  |  Compare to Other Systems  |  Compare to Paper Protocols

 When It Comes To Managing Glucose, It’s All About Outcomes.



The numbers above are based on over 100,000 patients who had their insulin dosing managed with GlucoStabilizer,
with nearly 3.5 million blood glucoses read and 110,000 drips administered.

GlucoStabilizer is a Proven Critical Tool for Critical Care

A tool that is easy to use and assists in making insulin infusion titrations based on metabolic parameters - more >

A tool with audible and visual alerts to remind you when to perform another glucose test.

A tool that can tailor insulin therapy to individual patients, both Adult and Pediatric, during their hospitalization.

A tool that can reduce transcription errors - more >

A tool used to calculate nearly 5 million insulin doses on over 150,000 patients - more >

A tool like GlucoStabilizer.

GlucoStabilizer By the Numbers

Time to Control of 170 mg/dL (hours)

All Patients with any BG reading 3.84 hours
Patients with initial BG < 600 mg/dL 3.62 hours

Patients with initial BG < 700 mg/dL

3.73 hours

Patients Achieving Control (%)
Patients with at least 4 BG entries 98.2%
Patients with at least 7 BG entries 99.3%

Rate of Hypoglycemia (%)*

Severe: < 40 mg/dL 0.015%
Mild: < 70 mg/dL 0.25%

Metrics from GlucoStabilizer customer data from Jan 2007 – Oct 2014. and includes 3,448,676 Blood Glucose (BG)
readings and 109,095 Drips.*Readings done within 15 minutes of recommended due time

GlucoStabilizer Compared to Other Systems

Burgess WP, Miller E, Dunn K. Tight Glucose Control for Critically Ill Patients Using EndoTool™ Software.Abstract for Journal of Diabetes Science and Technology Annual Meeting, Nov 2-4, 2006.
  Davidson PC, Steed RD, Bode BW: Glucommander: A computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care 2005; 28:2418-2423.
GlucoStabilizer Compared to Paper Protocols

Efficiency Parameters

Paper protocol*

Paper protocol**


ICU Patients- # used for calculation of subsequent data calculation

Not indicated in source



Total BG measurements (n)


454 (9-20/patient)


Time for Initiation of an infusion (minutes + SD)

Not indicated in source

32.56 + 12.83

8.2 + 3.2

Time for glucose measurement, insulin dose calculation and dose adjustment (minutes + SD)

4.72 + 1.13

10.65 + 3.24

3.2 + 1.1

Glucose measures reduced to Q2 hrs.

Not indicated in source

Not indicated in source

>54% measures

Safety Parameters

Time to Target as define by BG <110 mg/dl (hours)

Not indicated in source

> 12 hours

5.9 + 5.7

Hypoglycemia rate (< 40 mg/dL)




Protocol deviations- deviations from scheduled measurement

Not indicated in source

Total 734; 418 (57%)


D50 W calculation and return to glucose target range after hypoglycemia (minutes)



28.0 + 26.2

Other Parameters
Nursing Training time

35 minutes

35 minutes

10 minutes

From SCCM 2017: Revisiting Tight Glucose Control in the ICU:

Lower mortality risk with lower glucose target


More stringent glucose control in critically ill patients led to a lower mortality without a significant increase in severe hypoglycemia,

possibly reopening a discussion that many experts considered over, it was reported here. Patients treated to a glucose target of

80 to 110 mg/dL had a 36% lower 30-day mortality compared with patients treated to a target of 90 to 140 mg/dL.

The lower target was achieved with less than 1% incidence of severe hypoglycemia. more >

Publications on Glucose Control and Insulin Dosing

Software-Guided Insulin Dosing Decreases Glycemic Variability in Critically Ill Patients More >

Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose is performed frequently and on time More >

Errors in Insulin Dosing are Six Times

More Likely to Result in Harm to Patients

More >

Utilization of a Computerized Intravenous Insulin Infusion Program to Control Blood Glucose in the Intensive Care Unit More >

Glycemic Control and Decreased Glycemic Derangements in Critically Ill Patients

More >

Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action

More >


© 2018. All rights reserved. GlucoStabilizer is a trademark of Indiana University Health, Inc. under license.

* Aragon D, American Journal of Critical Care (July 2006);15:370-377 ** Maleskar et al., American Journal of Critical Care (Nov 2007), 16(6): 589-598 *** Clarian Data, on file at Medical Automation Systems, Inc.

This data was researched and produced by The Epsilon Group ( and published in the November 2008 issue of their Epsilon Evidentia newsletter.